Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Alberto Diaz De Leon Image

      Alberto Diaz De Leon, M.D.

      Department of Abdominal Imaging, Division of Diagnostic Imaging

      Present Title & Affiliation

      Primary Appointment

      Director of MRI, Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Associate Professor, Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2010The University of Texas Southwestern Medical Center, Dallas, Texas, US, Doctor of Medicine
      2005Texas A&M University, College Station, Texas, US, Molecular and Cell Biology, Bachelor of Science

      Postgraduate Training

      2015-2016Fellow, Magnetic Resonance Imaging, The University of Texas Southwestern School, Dallas, Texas
      2010-2015Resident, Radiology, The University of Texas Southwestern Medical Center, Dallas, Texas

      Licenses & Certifications

      2014Physician License

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, The University of Texas Southwestern Medical School, Dallas, Texas, 2016 - 2022

      Assistant Instructor, The University of Texas Southwestern Medical School, Dallas, Texas, 2015 - 2016

      Honors & Awards

      2010 - PresentDoris Duke Physician Scientist Research Fellowship, Doris Duke Foundation

      Selected Publications

      Peer-Reviewed Articles

      1. Landan MacDonald, Haesun Choi, Hyunseon Christine Kang, Diaz De Leon A, Irene Inguillo, Abhi Maharjan, Justin Gregg, John Ward. Is Confirmatory Prostate Biopsy Necessary in Active Surveillance Patients With an Initial Magnetic Resonance Imaging Ultrasound Fusion Biopsy? 3(8):e00083, 2025. e-Pub 2025.
      2. Diaz De Leon A, Haesun Choi, Diaz De Leon A, Hyunseon Christine Kang, Suprateek Kundu, Wei Qiao, Zhouxuan Li, Irene A. Inguillo, Abhi Maharjan, Justin R. Gregg, John F. Ward. Magnetic Resonance Imaging Ultrasound Volume Discrepancy as a Predictor of Magnetic Resonance Imaging Ultrasound Fusion-Guided Targeted Biopsy Performance. JU Open Plus 3(8):e00089, 2025.
      3. Taffel MT, Khatri G, Purysko AS, Avery R, Caserta MP, Chang SD, De Leon AD, Ganeshan D, Gupta RT, Lew SQ, Lyshchik A, Nicola R, Piel C Jr, Sener A, Smith AD, Nikolaidis P. ACR Appropriateness Criteria(R) Renal Transplant Dysfunction: 2024 Update. J Am Coll Radiol 22(5S):S372-S395, 2025. e-Pub 2025. PMID: 40409889.
      4. Brixey, AG, Fung, AW, Diaz De Leon, A, Walker, CM, Porter, KK, Khatri, G, Bang, TJ, Batra, K, Carter, B, Christensen, JD, Cox, CW, Davis, AM, Holley, AB, Kandathil, A, Little, BP, Madan, R, Mehta, P, Moore, W, Shroff, G, Uyeda, J, Nikolaidis, P, Kamel, IR, Chung, J. ACR Appropriateness Criteria® Sepsis. Journal of the American College of Radiology 21(6):S292-S309, 2024. e-Pub 2024. PMID: 38823951.
      5. Venishetty, N, Taylor, J, Xi, Y, Howard, JM, Ng, YS, Wong, D, Woldu, SL, Diaz De Leon, A, Pedrosa, I, Margulis, V, Bagrodia, A. Testicular Radiomics To Predict Pathology At Time of Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Tumor. Clinical Genitourinary Cancer 22(1):33-37, 2024. e-Pub 2024. PMID: 37468341.
      6. Recchimuzzi DZ, Diaz de Leon A, Pedrosa I, Travalini D, Latin H, Goldberg K, Meng X, Begovic J, Rayan J, Roehrborn CG, Rofsky NM, Costa DN. Direct MRI-guided In-Bore Targeted Biopsy of the Prostate: A Step-by-Step How To and Lessons Learned. Radiographics 44(2):e230142, 2024. e-Pub 2024. PMID: 38175803.
      7. Gupta RT, Kalisz K, Khatri G, Caserta MP, Catanzano TM, Chang SD, De Leon AD, Gore JL, Nicola R, Prabhakar AM, Savage SJ, Shah KP, Surabhi VR, Taffel MT, Valente JH, Yoo DC, Nikolaidis P. ACR Appropriateness Criteria(R) Acute Onset Flank Pain-Suspicion of Stone Disease (Urolithiasis). J Am Coll Radiol 20(11S):S315-S328, 2023. e-Pub 2023. PMID: 38040458.
      8. Ganeshan, DM, Khatri, G, Ali, N, Avery, RJ, Caserta, MP, Chang, S, Diaz De Leon, A, Gupta, RT, Lyshchik, A, Michalski, J, Nicola, R, Pierorazio, P, Purysko, AS, Smith, A, Taffel, MT, Nikolaidis, P. ACR Appropriateness Criteria® Staging of Renal Cell Carcinoma. Journal of the American College of Radiology 20(5):S246-S264, 2023. e-Pub 2023. PMID: 37236747.
      9. Costa DN, Meng X, Tverye A, Bagrodia A, Recchimuzzi DZ, Xi Y, Arraj P, Shah RB, Subramanian N, Diaz de Leon A, Roehrborn CG, Rofsky NM, Chen H, Pedrosa I. Preoperative multiparametric prostate magnetic resonance imaging structured report informs risk for positive apical surgical margins during radical prostatectomy. J Comput Assist Tomogr 47(1):38-44, 2023. e-Pub 2022. PMID: 35995580.
      10. Smith, A, Nikolaidis, P, Khatri, G, Chong, S, Diaz De Leon, A, Ganeshan, DM, Gore, JL, Gupta, RT, Kwun, R, Lyshchik, A, Nicola, R, Purysko, AS, Savage, SJ, Taffel, MT, Yoo, DC, Delaney, EW, Lockhart, M. ACR Appropriateness Criteria® Acute Pyelonephritis. Journal of the American College of Radiology 19(11):S224-S239, 2022. e-Pub 2022. PMID: 36436954.
      11. Purysko, AS, Nikolaidis, P, Khatri, G, Aurón-Gómez, M, Diaz De Leon, A, Ganeshan, DM, Gore, JL, Gupta, RT, Shek-Man Lo, S, Lyshchik, A, Savage, SJ, Smith, A, Taffel, MT, Yoo, DC, Lockhart, M. ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Carcinoma. Journal of the American College of Radiology 19(5):S156-S174, 2022. e-Pub 2022. PMID: 35550799.
      12. Hannan R, Mohamad O, Diaz de Leon A, Manna S, Pop LM, Zhang Z, Mannala S, Christie A, Christley S, Monson N, Ishihara D, Hsu EJ, Ahn C, Kapur P, Chen M, Arriaga Y, Courtney K, Cantarel B, Wakeland EK, Fu YX, Pedrosa I, Cowell L, Wang T, Margulis V, Choy H, Timmerman RD, Brugarolas J. Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma. Clin Cancer Res 27(24):6716-6725, 2021. e-Pub 2021. PMID: 34551906.
      13. Udayakumar D, Zhang Z, Xi Y, Dwivedi DK, Fulkerson M, Haldeman S, McKenzie T, Yousuf Q, Joyce A, Hajibeigi A, Notgrass H, de Leon AD, Yuan Q, Lewis MA, Madhuranthakam AJ, Sibley RC, Elias R, Guo J, Christie A, McKay RM, Cadeddu JA, Bagrodia A, Margulis V, Brugarolas J, Wang T, Kapur P, Pedrosa I. Deciphering Intratumoral Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma with a Radiogenomics Platform. Clin Cancer Res 27(17):4794-4806, 2021. e-Pub 2021. PMID: 34210685.
      14. Desai S, Jia L, Diaz de Leon A, Costa DN. Rare prostate cancer mimic on multiparametric MRI: Cowper's gland hyperplasia. Urol Case Rep 38:101675, 2021. e-Pub 2021. PMID: 33898268.
      15. Costa DN, Jia L, Subramanian N, Xi Y, Rofsky NM, Recchimuzzi DZ, de Leon AD, Arraj P, Pedrosa I. Prospective PI-RADS v2.1 Atypical Benign Prostatic Hyperplasia Nodules With Marked Restricted Diffusion: Detection of Clinically Significant Prostate Cancer on Multiparametric MRI. AJR Am J Roentgenol 217(2):395-403, 2021. e-Pub 2021. PMID: 32876473.
      16. Costa DN, Cai Q, Xi Y, Recchimuzzi DZ, Subramanian N, Bagrodia A, Rofsky NM, Roehrborn CG, Hornberger B, Shah RB, Goldberg K, Diaz de Leon A, Pedrosa I. Gleason Grade Group Concordance between Preoperative Targeted Biopsy and Radical Prostatectomy Histopathologic Analysis: A Comparison Between In-Bore MRI-guided and MRI-Transrectal US Fusion Prostate Biopsies. Radiol Imaging Cancer 3(2):e200123, 2021. e-Pub 2021. PMID: 33817652.
      17. Steinberg RL, Rasmussen RG, Johnson BA, Ghandour R, De Leon AD, Xi Y, Yokoo T, Kim S, Kapur P, Cadeddu JA, Pedrosa I. Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging. Eur Radiol 31(1):314-324, 2021. e-Pub 2021. PMID: 32770377.
      18. Subramanian N, Recchimuzzi DZ, Xi Y, Diaz de Leon A, Chen H, Xie D, Goldberg K, Rofsky NM, Pedrosa I, Costa DN. Impact of the Number of Cores on the Prostate Cancer Detection Rate in Men Undergoing in-Bore Magnetic Resonance Imaging-Guided Targeted Biopsies. J Comput Assist Tomogr 45(2):203-209, 2021. e-Pub 2021. PMID: 33273160.
      19. Courtney KD, Ma Y, Diaz de Leon A, Christie A, Xie Z, Woolford L, Singla N, Joyce A, Hill H, Madhuranthakam AJ, Yuan Q, Xi Y, Zhang Y, Chang J, Fatunde O, Arriaga Y, Frankel AE, Kalva S, Zhang S, McKenzie T, Reig Torras O, Figlin RA, Rini BI, McKay RM, Kapur P, Wang T, Pedrosa I, Brugarolas J. HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma. Clin Cancer Res 26(4):793-803, 2020. e-Pub 2020. PMID: 31727677.
      20. Khatri G, Pedrosa I, Ananthakrishnan L, de Leon AD, Fetzer DT, Leyendecker J, Singal AG, Xi Y, Yopp A, Yokoo T. Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: An equivalence study using LI-RADS v2018. J Magn Reson Imaging 51(2):415-425, 2020. e-Pub 2020. PMID: 31209978.
      21. Yokoo T, Singal AG, Diaz de Leon A, Ananthakrishnan L, Fetzer DT, Pedrosa I, Khatri G. Prevalence and clinical significance of discordant LI-RADS® observations on multiphase contrast-enhanced MRI in patients with cirrhosis. Abdom Radiol (NY) 45(1):177-187, 2020. e-Pub 2020. PMID: 31342103.
      22. Pirasteh A, Johnson B, Dimitrov IE, Costa DN, Diaz de Leon A, Xi Y, Madhuranthakam AJ, Pedrosa I. Turbo Spin-Echo Diffusion-Weighted Imaging in Prostate Magnetic Resonance Imaging of Men With Pelvic Hardware. J Comput Assist Tomogr 44(4):519-526, 2020. e-Pub 2020. PMID: 32697522.
      23. Johnson BA, Kim S, Steinberg RL, de Leon AD, Pedrosa I, Cadeddu JA. Diagnostic performance of prospectively assigned clear cell Likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging. Urol Oncol 37(12):941-946, 2019. e-Pub 2019. PMID: 31540830.
      24. Costa DN, Goldberg K, Leon AD, Lotan Y, Xi Y, Aziz M, Freifeld Y, Margulis V, Raj G, Roehrborn CG, Hornberger B, Desai N, Bagrodia A, Francis F, Pedrosa I, Cadeddu JA. Magnetic Resonance Imaging-guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate. Eur Urol Oncol 2(4):397-404, 2019. e-Pub 2019. PMID: 31277776.
      25. Vento J, Mulgaonkar A, Woolford L, Nham K, Christie A, Bagrodia A, de Leon AD, Hannan R, Bowman I, McKay RM, Kapur P, Hao G, Sun X, Brugarolas J. PD-L1 detection using (89)Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response. J Immunother Cancer 7(1):144, 2019. e-Pub 2019. PMID: 31155004.
      26. Freifeld Y, Diaz de Leon A, Xi Y, Pedrosa I, Roehrborn CG, Lotan Y, Francis F, Costa DN. Diagnostic performance of prospectively assigned likert scale scores to determine extraprostatic extension and seminal vesicle invasion With multiparametric MRI of the prostate. AJR Am J Roentgenol 212(3):576-581, 2019. e-Pub 2019. PMID: 30589381.
      27. Costa DN, Xi Y, Aziz M, Passoni N, Shakir N, Goldberg K, Francis F, Roehrborn CG, Leon AD, Pedrosa I. Prospective Inclusion of Apparent Diffusion Coefficients in Multiparametric Prostate MRI Structured Reports: Discrimination of Clinically Insignificant and Significant Cancers. AJR Am J Roentgenol 212(1):109-116, 2019. e-Pub 2019. PMID: 30383404.
      28. Diaz de Leon A, Leyendecker JR, Otero-Muinelo S, Grewal H, Xi Y, Francis F, Pedrosa I, Costa DN. Reproducibility of Index Lesion Size and Mean Apparent Diffusion Coefficient Values Measured by Prostate Multiparametric MRI: Correlation With Whole-Mount Sectioning of Specimens. AJR Am J Roentgenol 211(4):783-788, 2018. e-Pub 2018. PMID: 30160988.
      29. Diaz de Leon A, Costa DN, Francis F, Pedrosa I. Case 258: Granulomatous Prostatitis. Radiology 289(1):267-271, 2018. e-Pub 2018. PMID: 30230997.
      30. Diaz de Leon A, Costa DN, Francis F, Pedrosa I. Case 258. Radiology 287(3):1070-1072, 2018. e-Pub 2018. PMID: 29782240.
      31. Costa DN, Passoni NM, Leyendecker JR, de Leon AD, Lotan Y, Roehrborn CG, Otero-Muinelo S, Grewal H, Xi Y, Francis F, Rofsky NM, Pedrosa I. Diagnostic Utility of a Likert Scale Versus Qualitative Descriptors and Length of Capsular Contact for Determining Extraprostatic Tumor Extension at Multiparametric Prostate MRI. AJR Am J Roentgenol 210(5):1066-1072, 2018. e-Pub 2018. PMID: 29489410.
      32. Kay FU, Canvasser NE, Xi Y, Pinho DF, Costa DN, Diaz de Leon A, Khatri G, Leyendecker JR, Yokoo T, Lay AH, Kavoussi N, Koseoglu E, Cadeddu JA, Pedrosa I. Diagnostic Performance and Interreader Agreement of a Standardized MR Imaging Approach in the Prediction of Small Renal Mass Histology. Radiology 287(2):543-553, 2018. e-Pub 2018. PMID: 29390196.
      33. Mohamad O, Diaz de Leon A, Schroeder S, Leiker A, Christie A, Zhang-Velten E, Trivedi L, Khan S, Desai NB, Laine A, Albuquerque K, Iyengar P, Arriaga Y, Courtney K, Gerber DE, Hammers H, Choy H, Timmerman R, Brugarolas J, Hannan R. Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy. Oncoimmunology 7(7):e1440168, 2018. e-Pub 2018. PMID: 29900043.
      34. Canvasser NE, Kay FU, Xi Y, Pinho DF, Costa D, de Leon AD, Khatri G, Leyendecker JR, Yokoo T, Lay A, Kavoussi N, Koseoglu E, Cadeddu JA, Pedrosa I. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Identify Clear Cell Renal Cell Carcinoma in cT1a Renal Masses. J Urol 198(4):780-786, 2017. e-Pub 2017. PMID: 28457802.
      35. Zhang Y, Udayakumar D, Cai L, Hu Z, Kapur P, Kho EY, Pavia-Jimenez A, Fulkerson M, de Leon AD, Yuan Q, Dimitrov IE, Yokoo T, Ye J, Mitsche MA, Kim H, McDonald JG, Xi Y, Madhuranthakam AJ, Dwivedi DK, Lenkinski RE, Cadeddu JA, Margulis V, Brugarolas J, DeBerardinis RJ, Pedrosa I. Addressing metabolic heterogeneity in clear cell renal cell carcinoma with quantitative Dixon MRI. JCI Insight 2(15), 2017. e-Pub 2017. PMID: 28768909.
      36. de Leon AD, Xi Y, Champine J, Costa DN. Achieving ideal computed tomographic scan length in patient with suspected urolithiasis. J Comput Assist Tomogr 38(2):264-7, 2014. e-Pub 2014. PMID: 24448507.
      37. Diaz de Leon A, Cronkhite JT, Yilmaz C, Brewington C, Wang R, Xing C, Hsia CCW, Garcia CK. Subclinical lung disease, macrocytosis, and premature graying in kindreds with telomerase (TERT) mutations. Chest 140(3):753-763, 2011. e-Pub 2011. PMID: 21349926.
      38. Yilmaz C, Watharkar SS, Diaz de Leon A, Garcia CK, Patel NC, Jordan KG, Hsia CC. Quantification of regional interstitial lung disease from CT-derived fractional tissue volume: a lung tissue research consortium study. Acad Radiol 18(8):1014-23, 2011. e-Pub 2011. PMID: 21596593.
      39. Diaz de Leon A, Cronkhite JT, Katzenstein AL, Godwin JD, Raghu G, Glazer CS, Rosenblatt RL, Girod CE, Garrity ER, Xing C, Garcia CK. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS One 5(5):e10680, 2010. e-Pub 2010. PMID: 20502709.
      40. Parrott D, Yuan Q, Pinho D, Xi Y, Costa DN, Diaz De Leon A, Dakanali M, Sun X, Oz OK, Bowen S, Rofsky NM, Mathews D, Pedrosa I. Characterization of suspicious prostate lesions at multiparametric MRI with dynamic 68 Ga-Gozetotide PET/CT. PMID: 41077599.

      Review Articles

      1. Diaz de Leon A, Davenport MS, Silverman SG, Schieda N, Cadeddu JA, Pedrosa I. Role of Virtual Biopsy in the Management of Renal Masses. AJR Am J Roentgenol 212(6):1234-1243, 2019. e-Pub 2019. PMID: 30995092.
      2. de Leon AD, Kapur P, Pedrosa I. Radiomics in Kidney Cancer: MR Imaging. Magn Reson Imaging Clin N Am 27(1):1-13, 2019. e-Pub 2019. PMID: 30466904.
      3. Diaz de Leon A, Pirasteh A, Costa DN, Kapur P, Hammers H, Brugarolas J, Pedrosa I. Current Challenges in Diagnosis and Assessment of the Response of Locally Advanced and Metastatic Renal Cell Carcinoma. Radiographics 39(4):998-1016, 2019. e-Pub 2019. PMID: 31199711.
      4. Diaz de Leon A, Pedrosa I. Imaging and screening of kidney cancer. Radiol Clin North Am 55(6):1235-1250, 2017. e-Pub 2017. PMID: 28991563.
      5. Khatri G, de Leon AD, Lockhart ME. MR Imaging of the Pelvic Floor. Magn Reson Imaging Clin N Am 25(3):457-480, 2017. e-Pub 2017. PMID: 28668155.
      6. Diaz de Leon A, Costa D, Pedrosa I. Role of Multiparametric MR Imaging in Malignancies of the Urogenital Tract. Magn Reson Imaging Clin N Am 24(1):187-204, 2016. e-Pub 2016. PMID: 26613881.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top